| Market Cap | ₹8,465Cr |
| ROE | 5.17% |
| P/E Ratio(TTM) | 156.53 |
| EPS(TTM) | 1.24 |
| P/B Ratio | 10.01 |
| Dividend Yield | 0.00% |
| Industry P/E | 31.80 |
| Book Value | 19.40 |
| Debt to Equity | 0.61 |
| Face Value | 2 |
| Managing Director | Mr. Rajaram Narayanan |
| Founded | 1985 |
| NSE Symbol | SEQUENT |
| FUND NAME | AUM(%) |
|---|---|
| UTI Healthcare Fund Direct Growth | 2.07% |
| Quant Small Cap Fund Direct Plan Growth | 1.58% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.17 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 35.96 | ||
| Wockhardt | NA (0.00%) | -430.05 | ||
| Natco Pharma | NA (0.00%) | 9.79 |